Radscopal Radiotherapy Plus Immunotherapy for Chemotherapy-Ineligible Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer: A Single-Center, Open-Label, Phase II Study
PHASE2
The RADIANCE trial plans to enroll patients with chemotherapy-ineligible de...
Efficacy of Anti-CTLA-4 Antibody Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III Non-Small Cell Lung Cancer
PHASE2
This study aims to evaluate the major pathologic response (MPR) rate of neo...
A Phase II Clinical Study to Assess the Efficacy and Safety of IBI310 or Placebo Combined With Sintilimab for Advanced Cervical Cancer Subjects Who Have Failed or Cannot Tolerate First-line or Above Platinum-based Chemotherapy
PHASE2
This is a randomized, double-blind, controlled, parallel-cohort Phase II cl...
A Clinical Trial Evaluating the Efficacy and Safety of IBI310 in Combination With Sintilimab, for Neoadjuvant Treatment of MSI-H/dMMR Resectable Colon Cancer
PHASE3
Evaluate efficacy and safety of IBI310 (CTLA-4 antibody) in combination wit...
Single-arm, Phase II Clinical Study Evaluating the Safety and Efficacy of Sintilimab Combined With IBI-310 and Chemotherapy as Neoadjuvant Therapy for Locally Advanced Rectal Cancer
PHASE2
Observation and evaluation of the safety and efficacy of PD-1 antibody comb...
Status
Recruiting
Location
The First Affiliated Hospital,the Air Force Medical University